Funders
Main funder
NEMESIS - Novel effect biomarkers for metabolic disruptors: evidence on health impacts to answer science and policy needs
Leaders
Project introduction
The NEMESIS project brings together experts from multiple fields of research to answer persisting scientific uncertainties regarding chemical-induced metabolic disruption. The project receives its funding from EU’s research and innovation funding programme Horizon Europe, that aims to ensure its citizens’ are living and working in a health-promoting environment.
The project will utilize a battery of New Approach Methodologies (NAMs) including state-of-the-art in vitro and in vivo methods and systems biology approaches, as well as large cohort datasets to provide more comprehensive understanding of the underlying mechanisms of action of metabolic disruptors and their mixtures. The main purpose of this is to find new biomarkers for chemical-induced metabolic disruption for human risk assessment of chemicals.
News
-
EU grants 8 million euros funding for a research project coordinated by Professor Jaana Rysä to study the metabolic effects of environmental chemicalsEU grants 8 million euros funding for a research project coordinated by Professor Jaana Rysä to study the metabolic effects of environmental chemicals
Cooperation
Keywords
Leaders
Professors
-
Anna-Liisa Levonen-Harju
ProfessorA.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences -
Paavo Honkakoski
ProfessorSchool of Pharmacy, Faculty of Health Sciences
Senior Researchers
-
Vittorio Fortino
Academy Research FellowInstitute of Biomedicine, School of Medicine, Faculty of Health Sciences -
Jenni Küblbeck
Senior ResearcherA.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences
